Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2025-12-25 @ 3:19 AM
NCT ID:
NCT05730205
Eligibility Criteria:
Inclusion Criteria:
* Female aged 18-45
* Diagnosis of sickle cell disease (SS or SB0)
* Report of at least 1 vaso-occlusive pain episode per month on average in the previous 6 months
* Willing to discontinue any hormonal contraception at the time of enrollment. Washout period of 1 month required for all hormonal contraception prior to enrollment in the study.
* Access to a device with text messaging capability
* Must be able to read and understand English
* Willing to comply with study procedures
Exclusion Criteria:
* SC Disease
* Use of Depo Provera in the past 6 months
* Changes to sickle cell medications in the past 3 months
* Contraindications to use of Nexplanon device as per clinical standards
* Currently pregnant or pregnant within the last month or seeking to become pregnant
* Currently breastfeeding
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT05730205
Study Brief:
Protocol Section:
NCT05730205